Literature DB >> 18057180

Development and validation of a cell-based high-throughput screening assay for TRPM2 channel modulators.

Yumei Song1, Ben Buelow, Anne-Laure Perraud, Andrew M Scharenberg.   

Abstract

TRPM2 is a member of the transient receptor potential melastatin (TRPM)-related ion channel family. The activation of TRPM2 induced by oxidative/nitrosative stress leads to an increase in intracellular free Ca(2+). Although further progress in understanding TRPM2's role in cell and organism physiology would be facilitated by isolation of compounds able to specifically modulate its function in primary cells or animal models, no cell-based assays for TRPM2 function well suited for high-throughput screening have yet been described. Here, a novel suspension B lymphocyte cell line stably expressing TRPM2 was used to develop a cell-based assay. The assay uses the Ca(2+)-sensitive fluorescence dye, Fluo-4 NW (no wash), to measure TRPM2-dependent Ca(2+) transients induced by H(2)O(2) and N-methyl-N'-nitrosoguanidine in a 96-well plate format. Assay performance was evaluated by statistical analysis of the Z' factor value and was consistently greater than 0.5 under optimal conditions, suggesting that the assay is very robust. For assay validation, the effects of known inhibitors of TRPM2 and TRPM2 gating secondary messenger production were determined. Overall, the authors have developed a cell-based assay that may be used to identify TRPM2 ion channel modulators from large compound libraries.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057180     DOI: 10.1177/1087057107310986

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  7 in total

Review 1.  High throughput screening technologies for ion channels.

Authors:  Hai-bo Yu; Min Li; Wei-ping Wang; Xiao-liang Wang
Journal:  Acta Pharmacol Sin       Date:  2015-12-14       Impact factor: 6.150

2.  The Poly(ADP-ribose) polymerase PARP-1 is required for oxidative stress-induced TRPM2 activation in lymphocytes.

Authors:  Ben Buelow; Yumei Song; Andrew M Scharenberg
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

3.  Development and optimization of a high-throughput bioassay for TRPM7 ion channel inhibitors.

Authors:  Brandi Castillo; Peter Pörzgen; Reinhold Penner; F David Horgen; Andrea Fleig
Journal:  J Biomol Screen       Date:  2010-04-22

Review 4.  A Review on the Role of TRP Channels and Their Potential as Drug Targets_An Insight Into the TRP Channel Drug Discovery Methodologies.

Authors:  Hamideh P Fallah; Ekta Ahuja; Haoquan Lin; Jinlong Qi; Qian He; Shan Gao; Hailong An; Jian Zhang; Yongzhen Xie; Dong Liang
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

Review 5.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

6.  Scalaradial Is a Potent Inhibitor of Transient Receptor Potential Melastatin 2 (TRPM2) Ion Channels.

Authors:  John G Starkus; Peter Poerzgen; Kristine Layugan; Kelly Galbraith Kawabata; Jun-Ichi Goto; Sayuri Suzuki; George Myers; Michelle Kelly; Reinhold Penner; Andrea Fleig; F David Horgen
Journal:  J Nat Prod       Date:  2017-10-11       Impact factor: 4.050

7.  Structure/function analysis of PARP-1 in oxidative and nitrosative stress-induced monomeric ADPR formation.

Authors:  Ben Buelow; Burak Uzunparmak; Marcia Paddock; Andrew M Scharenberg
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.